Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3921717 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2006 | 5 Pages |
ObjectivesFetal hyperechogenic bowel (FEB) is associated with infection, chromosomal abnormalities and poor fetal outcome. FEB may result from an intrauterine fetal bowel cytokine-mediated inflammatory response. Since alterations in the levels of the cytokines interleukin (IL)-6, IL-8, IL-10, tumour necrosis factor (TNF)-α and interferon (IFN)-γ are associated with pregnancy complications and necrotizing enterocolitis, this study aimed: (i) to determine their involvement in the pathophysiology of FEB and (ii) to identify their role as amniotic fluid markers of this condition.Study designIn this prospective case-control study, amniotic fluid was collected by transabdominal amniocentesis from pregnant women with fetuses presenting (n = 10) – or not (n = 30) – with FEB during routine 18–20 week ultrasound scans. Cell-free amniotic fluid samples were analysed for cytokine concentrations by fluid-phase multiplex immunoassay. Data were compared by Mann–Whitney U-tests and Pearson correlations.ResultsAmniotic fluid IL-8 levels were significantly higher in the FEB group. There was a positive correlation between IL-6 and each of IL-8 and INF-γ, as well as between IL-8 and IL-10, and TNF-α and INF-γ.ConclusionsFEB likely ensues from a fetal inflammatory process involving IL-8 and, possibly, IL-6 and IL-10. This indicates the potential of immunomodulatory therapy in the management of FEB.